Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Unit Feb 2022 Am J Respir Crit Care Med Cyclosporin A Reveals Potent Antiviral Effects in Preclinical Models of SARS-CoV-2 Infection Autoren Sauerhering L et al. Feb 2022 Cells Dysregulated PI3K Signaling in B Cells of CVID Patients Autoren Harder I et al. Feb 2022 Trop Med Int Health Non-tuberculous mycobacteria isolation from presumptive tuberculosis patients in Lambaréné, Gabon Autoren Epola Dibamba Ndanga M et al. Feb 2022 Int J Environ Res Public Health Sexual and Reproductive Health during the COVID-19 Pandemic: Results from a Cross-Sectional Online Survey in Germany Autoren Räuchle J et al. Feb 2022 Molecules Synthesis, Structure-Activity Relationships, and Antiviral Profiling of 1-Heteroaryl-2-Alkoxyphenyl Analogs as Inhibitors of SARS-CoV-2 Replication Autoren Bardiot D et al. Feb 2022 Eur Respir J Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes Autoren DiNardo AR et al. Feb 2022 Liver Int The biliary microbiome in ischaemic-type biliary lesions can be shaped by stenting but is resilient to antibiotic treatment Autoren Klein F et al. Feb 2022 Mol Ther Nucleic Acids RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection Autoren Marx S et al. Feb 2022 Eur Respir J Aspergillus tracheobronchitis in COVID-19 ARDS patients - a cohort study Autoren Koehler P et al. Feb 2022 Mol Ther Nucleic Acids Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells Autoren Baron Y et al. Feb 2022 Genome Med Whole genome sequencing-based classification of human-related Haemophilus species and detection of antimicrobial resistance genes Autoren Diricks M et al. Feb 2022 Eur J Clin Microbiol Infect Dis Early post-discharge mortality in CAP: frequency, risk factors and a prediction tool Autoren Glöckner V et al. Feb 2022 JCI Insight ADAM8 signaling drives neutrophil migration and ARDS severity Autoren Conrad C et al. Feb 2022 Infection Creatine kinase-(MB) and hepcidin as candidate biomarkers for early diagnosis of pulmonary tuberculosis: a proof-of-concept study in Lambaréné, Gabon Autoren Essone PN et al. Feb 2022 PLoS ONE FluoRNT: A robust, efficient assay for the detection of neutralising antibodies against yellow fever virus 17D Autoren Scheck MK et al. Feb 2022 J Hepatol Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity Autoren Ghallab A et al. Feb 2022 Cell Rep SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse models Autoren Stolp B et al. Feb 2022 J Chem Inf Model Characterization of an Allosteric Pocket in Zika Virus NS2B-NS3 Protease Autoren Santos NP et al. Feb 2022 Viruses High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon Particles Autoren Lücke AC et al. Feb 2022 Comput Struct Biotechnol J Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing Autoren Luedemann M et al. Feb 2022 J Bacteriol NamZ1 and NamZ2 from the oral pathogen Tannerella forsythia are peptidoglycan processing exo-β-N-acetylmuramidases with distinct substrate specificity Autoren Borisova M et al. Feb 2022 Proc Natl Acad Sci U S A Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection Autoren Schuhenn J et al. Feb 2022 Clin Microbiol Infect Neutralizing antibody activity against the B.1.617.2 (delta) variant 8 months after two-dose vaccination with BNT162b2 in health care workers Autoren Benning L et al. Feb 2022 J Viral Hepat Soluble inflammatory mediators identify HCV patients who may be cured with four weeks of antiviral treatment Autoren Khera T et al. Feb 2022 JHEP Rep A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection Autoren Burm R et al. Pagination Previous page ‹‹ Seite 116 Seite 117 Seite 118 Seite 119 Current page 120 Seite 121 Seite 122 Seite 123 Seite 124 Seite 116 Seite 117 Seite 118 Seite 119 Seite 120 Seite 121 Seite 122 Seite 123 Seite 124 Next page ››
Feb 2022 Am J Respir Crit Care Med Cyclosporin A Reveals Potent Antiviral Effects in Preclinical Models of SARS-CoV-2 Infection Autoren Sauerhering L et al.
Feb 2022 Trop Med Int Health Non-tuberculous mycobacteria isolation from presumptive tuberculosis patients in Lambaréné, Gabon Autoren Epola Dibamba Ndanga M et al.
Feb 2022 Int J Environ Res Public Health Sexual and Reproductive Health during the COVID-19 Pandemic: Results from a Cross-Sectional Online Survey in Germany Autoren Räuchle J et al.
Feb 2022 Molecules Synthesis, Structure-Activity Relationships, and Antiviral Profiling of 1-Heteroaryl-2-Alkoxyphenyl Analogs as Inhibitors of SARS-CoV-2 Replication Autoren Bardiot D et al.
Feb 2022 Eur Respir J Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes Autoren DiNardo AR et al.
Feb 2022 Liver Int The biliary microbiome in ischaemic-type biliary lesions can be shaped by stenting but is resilient to antibiotic treatment Autoren Klein F et al.
Feb 2022 Mol Ther Nucleic Acids RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection Autoren Marx S et al.
Feb 2022 Eur Respir J Aspergillus tracheobronchitis in COVID-19 ARDS patients - a cohort study Autoren Koehler P et al.
Feb 2022 Mol Ther Nucleic Acids Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells Autoren Baron Y et al.
Feb 2022 Genome Med Whole genome sequencing-based classification of human-related Haemophilus species and detection of antimicrobial resistance genes Autoren Diricks M et al.
Feb 2022 Eur J Clin Microbiol Infect Dis Early post-discharge mortality in CAP: frequency, risk factors and a prediction tool Autoren Glöckner V et al.
Feb 2022 JCI Insight ADAM8 signaling drives neutrophil migration and ARDS severity Autoren Conrad C et al.
Feb 2022 Infection Creatine kinase-(MB) and hepcidin as candidate biomarkers for early diagnosis of pulmonary tuberculosis: a proof-of-concept study in Lambaréné, Gabon Autoren Essone PN et al.
Feb 2022 PLoS ONE FluoRNT: A robust, efficient assay for the detection of neutralising antibodies against yellow fever virus 17D Autoren Scheck MK et al.
Feb 2022 J Hepatol Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity Autoren Ghallab A et al.
Feb 2022 Cell Rep SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse models Autoren Stolp B et al.
Feb 2022 J Chem Inf Model Characterization of an Allosteric Pocket in Zika Virus NS2B-NS3 Protease Autoren Santos NP et al.
Feb 2022 Viruses High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon Particles Autoren Lücke AC et al.
Feb 2022 Comput Struct Biotechnol J Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing Autoren Luedemann M et al.
Feb 2022 J Bacteriol NamZ1 and NamZ2 from the oral pathogen Tannerella forsythia are peptidoglycan processing exo-β-N-acetylmuramidases with distinct substrate specificity Autoren Borisova M et al.
Feb 2022 Proc Natl Acad Sci U S A Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection Autoren Schuhenn J et al.
Feb 2022 Clin Microbiol Infect Neutralizing antibody activity against the B.1.617.2 (delta) variant 8 months after two-dose vaccination with BNT162b2 in health care workers Autoren Benning L et al.
Feb 2022 J Viral Hepat Soluble inflammatory mediators identify HCV patients who may be cured with four weeks of antiviral treatment Autoren Khera T et al.
Feb 2022 JHEP Rep A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection Autoren Burm R et al.
